Viking Therapeutics VKTX
NASDAQ VKTX
$28.44 -0.22 (-0.77%)
At close: Nov 11, 2026 · 4:00 PM EST

Viking Therapeutics (VKTX) Interest Expenses (2014 - 2026)

Updated

Analysis

Viking Therapeutics (VKTX) Interest Expenses (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 217.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Viking Therapeutics 3.65 Bn 884.58 Mn - 88,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 88,000.00
Mar 31, 2018 24,000.00
Mar 31, 2015 35,253.00
Mar 31, 2014 2,576.00
API Access

Viking Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=VKTX&period=max&api_key=YOUR_API_KEY